BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 8, 2002
View Archived Issues
Ortho-McNeil submits sNDA for Levaquin for nosocomial pneumonia
Read More
IND submitted for AGI-1096 in prevention of organ transplant rejection
Read More
Abgenix initiates phase II trial of ABX-EGF in prostate cancer
Read More
IND approval for NicOx's HCT-1026 for urinary incontinence
Read More
Antitrust clearance obtained for MedImmune's acquisition of Aviron
Read More
ISTA files initial section of Vitrase NDA
Read More
Antisoma and Abbott revise pemtumomab licensing agreement
Read More
CancerVax files IND application to conduct pivotal trials of Canvaxin in advanced colon cancer
Read More
Nucleotide inhibitors of HBV replication under development at Origenix
Read More
Early clinical data indicate safety and efficacy of ISS-1018 coadministered with HBsAg
Read More
In vitro profile of PNU-177553, a new oxazolidinone, described at ICAAC meeting
Read More
15-Methylketolide derivatives of erythromycin A designed by R.W. Johnson and Kosan
Read More
GSK will market Natrecor in Europe under new agreement with Scios
Read More
Lead A2A antagonist selected by Vernalis for further development as potential PD therapy
Read More
LY-570310, a new oral hepatitis C protease inhibitor, designated a development candidate
Read More
Bacterial FabI inhibitors as novel antibiotics; GSK discusses findings at ICAAC
Read More
Phase IIa results of ABX-IL-8 in rheumatoid arthritis do not warrant progression to phase IIb trials
Read More
Contraceptive gel enters clinical trials
Read More
NB-1011 enters phase I/II trial in colon cancer
Read More
FDA approves IND for Albuleukin to enter clinical trials in treatment of cancer
Read More
Versicor initiates phase III trial for anidulafungin in invasive aspergillosis
Read More
Inhibitors of sCD23 formation and TNF processing patented by GSK
Read More
Oxadiazole MMP inhibitors reported useful for renal diseases in Shionogi patent
Read More
GSK-3beta inhibitors and their use described in recent patent
Read More
Dual 5-HT1A autoreceptor antagonists and 5-HT uptake inhibitors designed by AHP
Read More
New somatostatin receptor agonists selective for sst2 subtype and potential uses thereof
Read More
MMP-2 inhibitors identified at Shionogi as anticancer agents
Read More